Invention Grant
US09255250B2 Isolated mouse or human cell having an exogenous transgene in an endogenous albumin gene
有权
在内源性白蛋白基因中具有外源转基因的分离的小鼠或人细胞
- Patent Title: Isolated mouse or human cell having an exogenous transgene in an endogenous albumin gene
- Patent Title (中): 在内源性白蛋白基因中具有外源转基因的分离的小鼠或人细胞
-
Application No.: US14096788Application Date: 2013-12-04
-
Publication No.: US09255250B2Publication Date: 2016-02-09
- Inventor: Philip D. Gregory , Katherine A. High
- Applicant: Sangamo BioSciences, Inc. , The Children's Hospital of Philadelphia
- Applicant Address: US CA Richmond US PA Philadelphia
- Assignee: Sangamo BioScience, Inc.,The Children's Hospital of Philadelphia
- Current Assignee: Sangamo BioScience, Inc.,The Children's Hospital of Philadelphia
- Current Assignee Address: US CA Richmond US PA Philadelphia
- Agency: Pasternak Patent Law
- Agent Dahna S. Pasternak
- Main IPC: C12N5/00
- IPC: C12N5/00 ; C12N5/10 ; A61K48/00
Abstract:
Cells and methods of using these cells for expressing a transgene expressing a protein that is aberrantly expressed in a metabolic disorders from a safe harbor locus.
Public/Granted literature
- US20140155468A1 METHODS AND COMPOSITIONS FOR REGULATION OF METABOLIC DISORDERS Public/Granted day:2014-06-05
Information query
